2,4,6-Trimethoxybenzaldehyde

2,4,6-Trimethoxybenzaldehyde

SCHEMBL34873

COc1cc(OC)c(C=O)c(OC)c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.74
LMNA P02545 2/20 0.62
ALDH1A1 P00352 5/20 0.55
CYP1A1 P04798 4/20 0.50
CYP1B1 Q16678 4/20 0.50
CYP1A2 P05177 4/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
PRKDC P78527 1/20 0.47
TSHR P16473 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP3A4 P08684 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
MAOA P21397 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,4,6-Trimethoxybenzaldehyde SCHEMBL28687257 0.98 ERN1 (0.71) ERN1LMNAALDH1A1CYP1A1CYP1B1
2,4,6-Trimethoxybenzaldehyde SCHEMBL28687256 0.96 ERN1 (0.75) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL3818395 0.88 ERN1 (0.60) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL30230047 0.87 ERN1 (0.65) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL349075 0.87 ERN1 (0.65) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL12311288 0.87 ERN1 (0.65) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL4099200 0.87 ERN1 (0.65) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL6541652 0.87 ERN1 (0.59) ERN1LMNAALDH1A1CYP1A1CYP1B1
2,4,6-Trimethoxybenzaldehyde SCHEMBL8703974 0.87 ALDH1A1 (0.71) ERN1LMNAALDH1A1CYP1A1CYP1B1
SCHEMBL6540782 0.87 LMNA (0.59) ERN1LMNAALDH1A1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
EP-4555060-A1 LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT The Procter & Gamble Company (US) 2025-05-21 EP claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
CN-119841875-A Preparation of resveratrol derivative based on ferrocene skeleton 天津中医药大学 2025-04-18 CN claimed
CN-119528906-A Azaspiro compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2025-02-28 CN claimed
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US claimed
US-12209232-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2025-01-28 US claimed
EP-4347728-A1 UV LED FREE RADICAL CURABLE INKJET INKS AGFA NV (BE) 2024-04-10 EP claimed
US-11918671-B2 Multi-tone hair dyeing method in three steps HENKEL AG & CO. KGAA (DE) 2024-03-05 US claimed
EP-0982302-A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them PHARMACIA & UPJOHN COMPANY (US) 2000-03-01 EP claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US claimed
EP-0703909-A1 $g(D)?6,7 -TAXOLS ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PHARMACIA & UPJOHN COMPANY (US) 1996-04-03 EP claimed
EP-0674630-A1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PHARMACIA & UPJOHN COMPANY (US) 1995-10-04 EP claimed
WO-1994029288-A1 Δ6,7-TAXOLS ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE UPJOHN COMPANY (US) 1994-12-22 WO claimed
WO-1994013655-A1 7-HALO- AND 7β,8β-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE UPJOHN COMPANY (US) 1994-06-23 WO claimed
EP-0259268-A1 Process for the preparation of optically active beta-lactams CIBA-GEIGY AG (CH) 1988-03-09 EP claimed
US-4545870-A TRIALKOXYBENZALDEHYDES AND ORGANIC ACID COLUMBIA CHEMICAL CORPORATION (US) 1985-10-08 US claimed
US-4473713-A Hydrolysis of aryl-aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-09-25 US claimed
EP-0075629-A1 Imidazole derivatives, their preparation, and their pharmaceutical compositions Sumitomo Chemical Industries Ltd. (JP) 1983-04-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051370-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS ERN1 2489/4885LMNA 87/4885ALDH1A1 3917/4885
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS ERN1 2797/4885LMNA 62/4885ALDH1A1 3361/4885
US-11918671-B2 Multi-tone hair dyeing method in three steps TYR, HAO2, HAAO ERN1 4459/4885LMNA 2896/4885ALDH1A1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.